MDDI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Medtronic Gets Approval for Revolutionary Diabetes System

Medtronic, Inc. announced that it has received FDA approval for the world's first insulin pump with real-time continuous glucose monitoring . The Minimed Paradigm will help patients take immediate action to correct or prevent problems related to glucose level.

The system has a sensor that relays glucose readings to the pump every five minutes. It is a step toward an automated system that would function like a human pancreas. FDA so far has been hesitant regarding any system that takes an action automatically.

500 characters remaining